期刊文献+

代谢综合征与慢性肾脏病 被引量:2

下载PDF
导出
摘要 1998年世界卫生组织提出了世界上第一个代谢综合征(metabolic syndrome,MS)的工作定义,2007年〈中国成人血脂异常防治指南〉结合中国人的实际情况对MS的组分量化指标修订如下,具备以下3项或3项以上,①腹部肥胖,腰围男性≥90cm、女性≥80cm;②三酰甘油(triglycerides,TG)≥1.7mmol/L;③高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)<1.04mmol/L;④血压≥ 17.3/11.3kPa;⑤空腹血糖≥6.1mmol/L或糖负荷2h血糖≥7.8mmol/L[1].目前大量的研究表明[2-3]MS与慢性肾脏病(chronic kidney disease,CKD)密切相关,MS相关的CKD患病率不断上升,已成为世界范围内不容忽视的公共卫生问题,其多个组分已被逐步认识为CKD的起始或进展危险因素.本文就MS与CKD的关系及防治策略做一综述.
作者 张裕 孙铸兴
出处 《河北医科大学学报》 CAS 2011年第12期1483-1486,共4页 Journal of Hebei Medical University
  • 相关文献

参考文献22

  • 1LEE JE,CHOI SY,HUH W,et al.Metabolic syndrome,C-reactive protein,and chronic kidney disease in nondiabetic,nonhypertensive adults[J].American Journal of Hypertension,2007,20(11):1189-1194.
  • 2彭翔,李瑛,李军,刘伏友,彭佑铭,孙林,周乐天,唐文彬,何雅忆,陈星,杨丽君,陈军,吴静文,彭金定,王德军,虞仁和.湖南省某乡村成年人群中代谢综合征与慢性肾脏病的关系[J].中华流行病学杂志,2009,30(12):1221-1225. 被引量:10
  • 3高丹,刘章锁,刘东伟,胡晓舟,王沛,施学忠.郑州市成年人代谢综合征与慢性肾脏病相关性研究[J].中华内分泌代谢杂志,2009,25(4):414-415. 被引量:7
  • 4ZIYADEH FH,WOLF G.Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy[J].Curr Diabetes Rev,2008,4(1):39-45.
  • 5KANWAR YS,SUN L,XIE P,et al.A glimpse of various pathogenetic mechanisms of diabetic nephropathy[J].Annu Rev Pathol,2011,28(6):395-423.
  • 6ABE H.Recent progress in understanding the molecular pathogenesis of diabetic nephropathy[J].Rinsho Byori,2011,59(2):179-186.
  • 7KUMAR PA,BROSIUS FC 3RD,MENON RK.The glomerular podocyte as a target of growth hormone action:implications for the pathogenesis of diabetic nephropathy[J].Curr Diabetes Rev,2011,7(1):50-55.
  • 8YOO TH,LI JJ,KIM JJ,et al.Activation of the rennin-angiotensin system within podocytes in diabetes[J].Kidney Int,2007,71(10):1019-1027.
  • 9KELLY KJ,BURFORD JL,DOMINGUEZ JH,et al.Dominguez.Postischemic inflammatory syndrome:a critical mechanism of progressionin diabetic nephropathy[J].Am J Physiol Renal Physiol,2009,297(4):923-931.
  • 10SADAYOSHI ITO MD.Controversies on Obesity and CKD[J].Circulation Journal,2010,74(3):428-429.

二级参考文献23

  • 1Tuttle KR. Renal manifestations of the metabolic syndrome. Nephrol Dial Transplant, 2005,20 ; 861-864.
  • 2Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report. Circulation, 2002,106 : 3143 -3421.
  • 3Levey AS,Eckardt KU,Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes ( KDIGO ). Kidney Int, 2005,67 : 2089- 2100.
  • 4Zhang L, Zuo L, Wang F, et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc, 2007,82: 822-827.
  • 5Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med, 2004,140 : 167-174.
  • 6Tozawa M, Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res, 2007,30:937-943.
  • 7Lucove J, Vupputuri S, Heiss G, et al. Metabolic syndrome and the development of CKD in American Indians : the Strong Heart Study. Am J Kidney Dis,2008, 51:21-28.
  • 8Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol, 2005,16:2134-2140.
  • 9Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet, 2005,365:1398-1405.
  • 10Zhang L, Zuo L, Wang F, et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc, 2007,82 : 822-827.

共引文献15

同被引文献26

  • 1MAIOLI M, TOSO A, LEONCINI M, et al. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis [ J ]. Circulation, 2012,125 (25) :3099 -3107.
  • 2MARENZI G, ASSANELLI E, CAMPODONICO J, et al. Acute kidney injury in ST-segment elevation acute myocardialinf,~rc~.ior~ complicated by cardiogenic shock at admission [ J ]. Crit Care Med,2010,38(2) :438 -444.
  • 3STOLKER JM, MCCULLOUGH PA, RAO S, et al. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography[ J]. J Am Coil Cardio1,2010,55 ( 14 ) : 1433 - 1440.
  • 4LISS P, PERSSON PB, HANSELL P, et al. Renal failure in 57 925 patients undergoing coronary procedures usingiso-osmolar or low-osmolar contrast media [ J ]. Kidney Int, 2006, 70 ( 10 ) : 1811 -1817.
  • 5GURM I-IS, DIXON SR, SMITH DE, et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions [ J ]. JAm Coil Cardiol,2011,58(9) :907 -914.
  • 6MEHRAN R, AYMONG ED, NIKOLSKY E, et al. A simple risk score for prediction of contrast-induced neplropathy after pereutaneous coronary intervention: development and initial vaidation[ J]. J Am Coll Cardiol,2004,44(7) :1393 - 1399.
  • 7KLIMA T, CHRIST A, MARANA I, et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephmpathy: a randomized controlled trial [ J ]. Eur Heart J, 2012,33(16) :2071 -2079.
  • 8CRUZ DN, GOH CY, MARENZI G, et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review[ J ]. Am J Med,2012,125 ( 1 ) :66 - 78.
  • 9SONG K, JIANG S, SHI Y, et al. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta- analysis of randomized controlled trials[ J]. Am J Nephro1,2010, 32(5) :497 -504.
  • 10KHANAL S, ATTALLAH N, SMITH DE, et al. Statin therapy reduces contrastinducod nephropathy :an analysis of contemporary percutaneous interventions[J]. Am J Med ,2005,118 ( 8 ) : 843 - 849.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部